Skip to main content
Caplight Logo









Galenvs Sciences

Galenvs Sciences

Private
MontrealHealthcare & Life Scienceshttps://galenvs.com/

Last Round

Accelerator

Dec 12, 2024

Total Funding Raised

$960,000

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Galenvs Sciences is a biotechnology company that develops and manufactures nanomaterials and DNA/RNA oligonucleotides for diagnostic and therapeutic applications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Advanced Materials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Usage-Based SaaS

AI Layer

Non-AI

Keywords

CDMOcontract development and manufacturing organizationoligonucleotide synthesismagnetic nanomaterialsnucleic acid extractionbiomanufacturinglab automationbioseparationmolecular biology toolscustom oligonucleotidesmagnetic beadsbiotech supply chainCROcontract research organizationlab reagents

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Galenvs Sciences Comparables

Compare Galenvs Sciences with similar companies based on industry and business-model similarity.

Galenvs Sciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ademtech SA
74%
SIRION Biotech
73%
Twist Bioscience Corporation
71%

Galenvs Sciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorDec 12, 2024
GrantOct 28, 2024
GrantJan 27, 2022
GrantAug 24, 2020

Galenvs Sciences Investors

Notable investors and investment history

Galenvs Sciences investors
InvestorRounds
Emergence IncubatorAccelerator
National Research Council of CanadaGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 1033% MoM, from 251 to 2.8K.

  • Apr 3, 2026

    Monthly visitors increased 63% MoM.

Galenvs Sciences Filings

Explore SEC and related filing metadata, where available.

Galenvs Sciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Galenvs Sciences's valuation, stock price, and market status.

Is Galenvs Sciences a public or private company?

Galenvs Sciences is a private company.

What is the current stock price of Galenvs Sciences?

Galenvs Sciences is a private company, so its shares have no public market price. Caplight tracks Galenvs Sciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Galenvs Sciences worth (valuation)?

Valuation information for Galenvs Sciences is not publicly available.

Can I buy Galenvs Sciences stock?

Galenvs Sciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Galenvs Sciences's last funding round?

Galenvs Sciences's most recent funding round was Accelerator on December 12, 2024.

Who are the main investors in Galenvs Sciences?

Key investors in Galenvs Sciences include Emergence Incubator, National Research Council of Canada.

Will Galenvs Sciences IPO soon?

No public IPO plans have been announced for Galenvs Sciences.

How can I track Galenvs Sciences secondary market activity?

Caplight tracks bids, offers, and trades in Galenvs Sciences's shares on secondary markets.

Firmographic Details

HeadquartersMontreal
Employee Range13
Year FoundedN/A
Last FundingDec 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?